Nkarta (NKTX) Operating Expenses (2019 - 2026)
Nkarta (NKTX) posted quarterly Operating Expenses of $30.9 million for Q1 2026, down 15.56% year-over-year from $36.6 million in Q1 2025, and little changed quarter-over-quarter from $31.0 million in Q4 2025.
Nkarta (NKTX) Operating Expenses (2019 - 2026) Analysis & Trends
Nkarta's Operating Expenses history runs 8 years deep, the most recent figure standing at $30.9 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 15.56% year-over-year to $30.9 million; the TTM figure through Mar 2026 stood at $116.3 million (down 11.88% YoY), while the FY2025 annual figure was $122.0 million, down 4.83% from the prior year.
- Operating Expenses for Q1 2026 stood at $30.9 million, roughly flat from $31.0 million in the prior quarter.
- The five-year high for Operating Expenses was $36.9 million in Q2 2023, with the low at $26.1 million in Q1 2022.
- The 5-year median for Operating Expenses is $30.9 million (2024), against an average of $31.3 million.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses surged 52.85% in 2022, then dropped 19.26% in 2025.
- Nkarta's Operating Expenses stood at $35.0 million in 2022, then fell by 10.86% to $31.2 million in 2023, then decreased by 0.84% to $30.9 million in 2024, then advanced by 0.12% to $31.0 million in 2025, then dropped by 0.27% to $30.9 million in 2026.
- Business Quant data shows NKTX's Operating Expenses at $30.9 million in Q1 2026, $31.0 million in Q4 2025, and $27.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Nkarta | 185.49 Mn | 185.49 Mn | - | 43.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.13 Mn |
| Mar 31, 2026 | 30.88 Mn |
| Dec 31, 2025 | 30.96 Mn |
| Sep 30, 2025 | 27.29 Mn |
| Jun 30, 2025 | 27.19 Mn |
| Mar 31, 2025 | 36.56 Mn |
| Dec 31, 2024 | 30.92 Mn |
| Sep 30, 2024 | 33.79 Mn |
| Jun 30, 2024 | 30.72 Mn |
| Mar 31, 2024 | 32.76 Mn |
| Dec 31, 2023 | 31.19 Mn |
| Sep 30, 2023 | 29.29 Mn |
| Jun 30, 2023 | 36.86 Mn |
| Mar 31, 2023 | 34.31 Mn |
| Dec 31, 2022 | 34.98 Mn |
| Sep 30, 2022 | 30.26 Mn |
| Jun 30, 2022 | 27.61 Mn |
| Mar 31, 2022 | 26.10 Mn |
| Dec 31, 2021 | 22.89 Mn |
| Sep 30, 2021 | 22.43 Mn |